“Wound Debridement Market is expected to Reach $1.92 Billion By 2029”, says Visiongain report

08 January 2020
Pharma

Visiongain’s new report the Wound Debridement Market Report 2019-2029: Forecasts by Product (Gels, Ointments & Creams, Surgical Devices, Medical Gauzes, Mechanical Debridement Pads, Ultrasonic Devices, Others), by Wound Type (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical & Traumatic Wounds, Burns, Others), by Method (Autolytic Methods, Enzymatic Methods, Surgical Methods, Mechanical Methods, Others), by End User (Hospitals, Clinics, Others), plus analysis of leading companies operating in the global wound debridement market.

Increasing prevalence of diabetes and associated wounds, rising aging population in developed as well as developing economies, increasing incidences if burn injuries and increasing awareness regarding wound care management are expected to spur global wound debridement market over the forecast period. In 2019, the global wound debridement market was valued at $830 million and is expected to reach $1.92 billion by 2029 at a healthy growth rate of 8.7%.

Growing incidences of diabetes, pressure ulcers, and other chronic diseases are encouraged wound care management providers over the past few years and the trend is expected to continue over the coming years. According to the World Health Organization, in 1980, the number of people diagnosed with diabetes was nearly 108 million and this figure has increased to more than 450 million in 2018. Additionally, a hectic lifestyle, increasing working hours, and an unhealthy diet has resulted in increased prevalence of diabetes in the young population. For instance, according to the World Health Organization, the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to more than 9% in 2018.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever